Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Mol Cancer Ther. 2016 Nov 11;16(1):239–250. doi: 10.1158/1535-7163.MCT-16-0290

Figure 4. RECQL1 depletion and cell cycle progression.

Figure 4

A. Cell cycle distributions of MDA-MB-231 cells stably transduced with either control or RECQL1 shRNA at the indicated times following recovery from doxorubicin treatment (0.1 μM for 4 h). B. Data shown represent the average from two independent experiments with associated SEMs. Individual p values are summarized as a table here. C. Sub-G1 population in control and RECQL1-depleted MDA-MB-231 cells after doxorubicin treatment (0.1 μM) for indicated time. D. Data shown represent the average from two independent experiments with associated SEMs. Individual p values are summarized as a table here.